LJ
Luiza Jedlina
Chief Scientific Officer (CSO)
AptahemAptahem Pipeline
| Drug | Indication | Phase |
|---|
| Apta-1 | Sepsis (Emergency treatment to prevent organ failure) | Pre-clinical |
| Apta-2 | Coagulation/Immune Disorder (unspecified) | Pre-clinical |
| Apta-3 | Coagulation/Immune Disorder (unspecified) | Pre-clinical |